RxSight Inc (RXST)
44.83
-0.22
(-0.49%)
USD |
NASDAQ |
Nov 22, 16:00
44.85
+0.02
(+0.04%)
After-Hours: 20:00
RxSight Cash from Financing (Quarterly): 0.878M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.878M |
| June 30, 2024 | 111.47M |
| March 31, 2024 | 7.992M |
| December 31, 2023 | 3.562M |
| September 30, 2023 | -8.234M |
| June 30, 2023 | 0.891M |
| March 31, 2023 | 65.30M |
| December 31, 2022 | 6.307M |
| September 30, 2022 | -0.455M |
| June 30, 2022 | 0.578M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.098M |
| December 31, 2021 | 0.404M |
| September 30, 2021 | 120.55M |
| June 30, 2021 | 10.25M |
| March 31, 2021 | 6.144M |
| December 31, 2020 | 24.33M |
| September 30, 2020 | 0.052M |
| June 30, 2020 | 0.782M |
| March 31, 2020 | 0.075M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-8.234M
Minimum
Sep 2023
120.55M
Maximum
Sep 2021
18.46M
Average
0.891M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Tandem Diabetes Care Inc | -4.519M |
| PROCEPT BioRobotics Corp | 1.715M |
| Perspective Therapeutics Inc | 0.628M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.65M |
| Cash from Investing (Quarterly) | -9.26M |
| Free Cash Flow | -27.17M |
| Free Cash Flow Per Share (Quarterly) | -0.0114 |
| Free Cash Flow to Equity (Quarterly) | -0.453M |
| Free Cash Flow to Firm (Quarterly) | -0.453M |
| Free Cash Flow Yield | -1.60% |